Today: 17 May 2026
Browse Category

OTCQX:FMCC 16 March 2026 - 9 April 2026

Mortgage Rates Today: 30-Year Fixed Slips From Recent Highs as Treasury Yields Fall, Mortgage Stocks Split

Mortgage Rates Today: 30-Year Fixed Slips From Recent Highs as Treasury Yields Fall, Mortgage Stocks Split

U.S. 30-year fixed mortgage rates fell to 6.36% Monday, down from 6.41% Friday, as the 10-year Treasury yield slipped to 4.224%. Existing-home sales rose 1.7% in February, while mortgage applications and builder sentiment showed uneven demand. Rocket Companies shares gained 4.5%, but UWM Holdings and loanDepot declined. Markets expect the Fed to hold rates steady this week.

Stock Market Today

  • China Market Regulator Outlines 34 Priorities to Boost Private Sector Growth in 2026
    May 17, 2026, 2:21 AM EDT. China's market watchdog detailed 34 key priorities for 2026 aimed at supporting private sector growth. The focus includes promoting fair competition, enhancing legal protections, and streamlining regulation to foster a more conducive business environment. These measures signal Beijing's commitment to sustain private enterprises amid economic pressures.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop